Incidence of heparin-induced thrombocytopenia type II and relationship with anti-heparin/PF4 antibody (2007)
- Authors:
- Autor USP: BYDLOWSKI, SERGIO PAULO - FM
- Unidade: FM
- Subjects: ANTICOAGULANTES; TROMBOSE; ANTICORPOS
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do HC-FMUSP"
-
ABNT
OLIVEIRA, S. C. et al. Incidence of heparin-induced thrombocytopenia type II and relationship with anti-heparin/PF4 antibody. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 21 jan. 2026. , 2007 -
APA
Oliveira, S. C., Cavalheiro Filho, C., Rached, R. A., & Bydlowski, S. P. (2007). Incidence of heparin-induced thrombocytopenia type II and relationship with anti-heparin/PF4 antibody. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Oliveira SC, Cavalheiro Filho C, Rached RA, Bydlowski SP. Incidence of heparin-induced thrombocytopenia type II and relationship with anti-heparin/PF4 antibody. Clinics. 2007 ; 62 S166.[citado 2026 jan. 21 ] -
Vancouver
Oliveira SC, Cavalheiro Filho C, Rached RA, Bydlowski SP. Incidence of heparin-induced thrombocytopenia type II and relationship with anti-heparin/PF4 antibody. Clinics. 2007 ; 62 S166.[citado 2026 jan. 21 ] - Frequência das mutações GLN192ARG e LEU55MET no gene da paraoxonase 1 e das mutações SER311CIS e A148G no gene da paraoxonase 2 em brasileiros de diferentes origens étnicas
- The effect of sildenafil in the multimeric composition of plasma von Willebrand factor in pulmonary hypertension: preliminary study
- Células-tronco do líquido anmiótico
- Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years
- Flow-dependent Cardiac Dysfunction and Pressure-dependent Endothelial Activation in Patients With Atrial Septal Defect
- Detection of lung resistance-related protein (LRP) expression by RT-PCR in dogs with multicentric lymphoma
- Fibrinogen as auxiliary marker of atherogenic risk in HIV-1-infected
- Caracterização dos genes de resistência a múltiplas drogas (MDR1, MRP e LRP), em células de saracoma uterino, sensíveis e resistentes à doxorrubicina, in vitro
- Terapia celular é a medicina do futuro? [Editorial]
- Frequency of the paraoxonase 1 and 2 genetic polymorphisms and analysis of the PON1 enzyme' s activity in hiv positive patients
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
